Skip to main content
KBS_Icon_questionmark link-ico

 

IBD-BOOST Programme

IBD Boost

Fatigue, pain and urgency are a huge burden for many people living with inflammatory bowel disease and can persist even when in remission. IBD-BOOST aims to develop and evaluate ways to improve the well-being of people who experience them.

Inflammatory Bowel Disease (IBD) affects 300,000 people in the UK alone, causing unpredictable bouts of gut inflammation, with acute illness, diarrhoea, and pain. There is no current cure for IBD, which usually starts in childhood or as a young adult. IBD research has mostly focused on controlling inflammation. However, many people report continuing IBD-related fatigue, abdominal pain and urgency (urgent need to use the toilet) and incontinence when in remission. These symptoms limit peoples’ quality of life and ability to work and socialise.

Our research programme focuses on the development and evaluation of management interventions to improve the well-being of people with IBD by relieving these most common and troublesome chronic symptoms and enhancing quality of life.

The IBD-BOOST Programme is led by Christine Norton, Professor of Nursing in the Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care at King's. The programme co-investigators include academics, clinicians, people living with IBD and members of Crohn’s and Colitis UK.

 Find out more about our individual studies in the projects tab below

Our partners

IBD-BOOST is funded by the National Institute of Health Research and hosted by London North West Healthcare NHS Trust. The research is conducted by King’s College London in partnership with Queen Mary University of London, NHS Trusts and Crohn’s & Colitis UK.

National Institute for Health Research

London North West University Healthcare NHS Trust

Pragmatic Clinical Trials Unit

Crohn's and Colitis UK

Contact us

0207 848 3318

IBD-BOOST
King’s College London
James Clerk Maxwell Building
57 Waterloo Road
London SE1 8WA